California
Palm Desert; Desert Medical Advances
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
Florida
Tampa; Tampa Medical Group, P.A.
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
Indiana
Indianapolis; Physicians Research Group
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
Kentucky
Elizabethtown; Center for Arthritis & Osteoporosis
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
Maine
Bangor; Maine Center for Osteoporosis
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
Massachusetts
Boston; MGH - Massachusetts General Hospital
Effects of supraphysiological rhGH on bone metabolism in Anorexia Nervosa
Michigan
Detroit; Michigan Bone & Mineral Clinic
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
Ohio
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
Etanercept (Enbrel) in Children with Fanconi Anemia and Early Bone Marrow Failure, A Pilot Study
Pennsylvania
Pittsburgh; Osteoporosis Prevention & Treatment Center
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
Wyomissing; Radiant Research
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
South Carolina
Anderson; Radiant Research Inc.
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
Tennessee
Memphis; Summit Research Solutions
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
Texas
San Antonio; Diabetes and Glandular Disease Research
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
Virginia
Richmond; National Clinical Research
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
International
Montreal, QC, Canada; Montreal Clinical Study Centre Inc.
A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
